Skip to content
Logo of UK Clinical Research Delivery, a UK-based clinical research organisation
  • Governance
  • News & Updates
    • Latest UK Clinical Research Update
      • Archive: UK Clinical Research Updates
    • Clinical Research Bulletins and Key Policy Documents
    • UK Clinical Research Delivery Performance Indicators Report
  • UKCRD Projects
    • Study Set-up
      • Study Set-Up: Latest news
        • Bulletin: Action to enhance visibility of current research delivery set up activities in the UK
        • Webinar: Streamlining and reform of study set-up
        • Study Set-Up Plan: Phase 1 Completed
        • Bulletin: Requirement for use of the Schedule of Events Cost Attribution Tool (SoECAT) and the unmodifiable existing model Non-Commercial Agreement (mNCA) and Organisation Information Document (OID)
        • Study Set-Up Plan: Phase 2 Completed
        • Study Set-Up Plan: Questions
        • Webinar: Study Set-Up Plan update Progress and next steps
        • Action to enhance visibility of clinical research delivery against the UK government’s commitment to reduce the set-up time for clinical trials to less than 150 days
        • UKCRD Priority to streamline and reform the set-up and delivery of clinical trials Frequently Asked Questions (FAQs)
        • Guidance on detailed definitions and processes for site-level performance reporting
        • NIHR support for 150-day study set-up for clinical trials
        • Guidance on interpretation of IR(ME)R in NHS research
        • Updates to RDN Portfolio Eligibility Criteria
      • Study Set-Up: Trust level set up report
      • Study Set-Up: Policy Statement
    • Primary and Community Care
    • Research Delivery Data & Intelligence (RDDI)
      • RDDI: Q&A
      • RDDI: Latest news
        • March 2026 Update
  • Contact
  • Governance
  • News & Updates
    • Latest UK Clinical Research Update
      • Archive: UK Clinical Research Updates
    • Clinical Research Bulletins and Key Policy Documents
    • UK Clinical Research Delivery Performance Indicators Report
  • UKCRD Projects
    • Study Set-up
      • Study Set-Up: Latest news
        • Bulletin: Action to enhance visibility of current research delivery set up activities in the UK
        • Webinar: Streamlining and reform of study set-up
        • Study Set-Up Plan: Phase 1 Completed
        • Bulletin: Requirement for use of the Schedule of Events Cost Attribution Tool (SoECAT) and the unmodifiable existing model Non-Commercial Agreement (mNCA) and Organisation Information Document (OID)
        • Study Set-Up Plan: Phase 2 Completed
        • Study Set-Up Plan: Questions
        • Webinar: Study Set-Up Plan update Progress and next steps
        • Action to enhance visibility of clinical research delivery against the UK government’s commitment to reduce the set-up time for clinical trials to less than 150 days
        • UKCRD Priority to streamline and reform the set-up and delivery of clinical trials Frequently Asked Questions (FAQs)
        • Guidance on detailed definitions and processes for site-level performance reporting
        • NIHR support for 150-day study set-up for clinical trials
        • Guidance on interpretation of IR(ME)R in NHS research
        • Updates to RDN Portfolio Eligibility Criteria
      • Study Set-Up: Trust level set up report
      • Study Set-Up: Policy Statement
    • Primary and Community Care
    • Research Delivery Data & Intelligence (RDDI)
      • RDDI: Q&A
      • RDDI: Latest news
        • March 2026 Update
  • Contact

Webinar: Streamlining and reform of study set-up

Watch the webinar

Click the image or here to watch the webinar

  • Study Set-up
  • Study Set-Up: Latest news
    • Bulletin: Action to enhance visibility of current research delivery set up activities in the UK
    • Webinar: Streamlining and reform of study set-up
    • Study Set-Up Plan: Phase 1 Completed
    • Bulletin: Requirement for use of the Schedule of Events Cost Attribution Tool (SoECAT) and the unmodifiable existing model Non-Commercial Agreement (mNCA) and Organisation Information Document (OID)
    • Study Set-Up Plan: Phase 2 Completed
    • Study Set-Up Plan: Questions
    • Webinar: Study Set-Up Plan update Progress and next steps
    • Action to enhance visibility of clinical research delivery against the UK government’s commitment to reduce the set-up time for clinical trials to less than 150 days
    • UKCRD Priority to streamline and reform the set-up and delivery of clinical trials Frequently Asked Questions (FAQs)
    • Guidance on detailed definitions and processes for site-level performance reporting
    • NIHR support for 150-day study set-up for clinical trials
    • Guidance on interpretation of IR(ME)R in NHS research
    • Updates to RDN Portfolio Eligibility Criteria
  • Study Set-Up: Trust level set up report
  • Study Set-Up: Policy Statement
Logo of UK Clinical Research Delivery, a UK-based clinical research organisation

This website is for audiences interested in the cross-sector development and progression of the UK’s clinical research system. The site is managed by NIHR on behalf of all of the Programme partners.

Study Set-up
  • Governance
  • News & Updates
    • Latest UK Clinical Research Update
      • Archive: UK Clinical Research Updates
    • Clinical Research Bulletins and Key Policy Documents
    • UK Clinical Research Delivery Performance Indicators Report
  • UKCRD Projects
    • Study Set-up
      • Study Set-Up: Latest news
        • Bulletin: Action to enhance visibility of current research delivery set up activities in the UK
        • Webinar: Streamlining and reform of study set-up
        • Study Set-Up Plan: Phase 1 Completed
        • Bulletin: Requirement for use of the Schedule of Events Cost Attribution Tool (SoECAT) and the unmodifiable existing model Non-Commercial Agreement (mNCA) and Organisation Information Document (OID)
        • Study Set-Up Plan: Phase 2 Completed
        • Study Set-Up Plan: Questions
        • Webinar: Study Set-Up Plan update Progress and next steps
        • Action to enhance visibility of clinical research delivery against the UK government’s commitment to reduce the set-up time for clinical trials to less than 150 days
        • UKCRD Priority to streamline and reform the set-up and delivery of clinical trials Frequently Asked Questions (FAQs)
        • Guidance on detailed definitions and processes for site-level performance reporting
        • NIHR support for 150-day study set-up for clinical trials
        • Guidance on interpretation of IR(ME)R in NHS research
        • Updates to RDN Portfolio Eligibility Criteria
      • Study Set-Up: Trust level set up report
      • Study Set-Up: Policy Statement
    • Primary and Community Care
    • Research Delivery Data & Intelligence (RDDI)
      • RDDI: Q&A
      • RDDI: Latest news
        • March 2026 Update
  • Contact
Main menu
  • Study Set-up
  • Study Set-Up: Latest news
    • Bulletin: Action to enhance visibility of current research delivery set up activities in the UK
    • Webinar: Streamlining and reform of study set-up
    • Study Set-Up Plan: Phase 1 Completed
    • Bulletin: Requirement for use of the Schedule of Events Cost Attribution Tool (SoECAT) and the unmodifiable existing model Non-Commercial Agreement (mNCA) and Organisation Information Document (OID)
    • Study Set-Up Plan: Phase 2 Completed
    • Study Set-Up Plan: Questions
    • Webinar: Study Set-Up Plan update Progress and next steps
    • Action to enhance visibility of clinical research delivery against the UK government’s commitment to reduce the set-up time for clinical trials to less than 150 days
    • UKCRD Priority to streamline and reform the set-up and delivery of clinical trials Frequently Asked Questions (FAQs)
    • Guidance on detailed definitions and processes for site-level performance reporting
    • NIHR support for 150-day study set-up for clinical trials
    • Guidance on interpretation of IR(ME)R in NHS research
    • Updates to RDN Portfolio Eligibility Criteria
  • Study Set-Up: Trust level set up report
  • Study Set-Up: Policy Statement